Conmed Corp (CNMD) Reports In-Line Q2 EPS; Guides Q3
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Join SI Premium – FREE
Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $183.2 million versus the consensus estimate of $185.81 million.
Conmed Corp sees Q3 2011 EPS of $0.29-$0.33, versus the consensus of $0.33. Sees revs down slightly sequentially.
Conmed Corp sees Q3 2011 EPS of $0.29-$0.33, versus the consensus of $0.33. Sees revs down slightly sequentially.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sotera Health Co. (SHC) Tops Q3 EPS by 2c; Offers Guidance
- Expeditors Int'l (EXPD) Tops Q3 EPS by 45c
- Sotera Health Co. (SHC) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
